SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-19-028231
Filing Date
2019-05-09
Accepted
2019-05-09 16:40:25
Documents
4
Effectiveness Date
2019-05-09

Document Format Files

Seq Description Document Type Size
1 S-8 a19-9591_1s8.htm S-8 112259
2 EX-5.1 a19-9591_1ex5d1.htm EX-5.1 26800
3 EX-23.1 a19-9591_1ex23d1.htm EX-23.1 2209
4 GRAPHIC g95911kii001.gif GRAPHIC 2562
  Complete submission text file 0001104659-19-028231.txt   145953
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-231331 | Film No.: 19811252
SIC: 2834 Pharmaceutical Preparations